FDA Inspection 1036908 — Heartland Center For Reproductive Medicine, PC
The FDA completed an inspection of Heartland Center For Reproductive Medicine, PC on Nov 30, 2017 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 30, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Omaha, NE (United States)